Free Trial

Canopy Growth (WEED) Stock Forecast & Price Target

C$10.20
+0.42 (+4.29%)
(As of 10:03 AM ET)

Canopy Growth - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 5 Wall Street analysts who have issued ratings for Canopy Growth in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 5 analysts, 2 have given a sell rating, and 3 have given a hold rating for WEED.

Consensus Price Target

C$6.88
-32.59% Downside
High ForecastC$11.00
Average ForecastC$6.88
Low ForecastC$1.80

According to the 5 analysts' twelve-month price targets for Canopy Growth, the average price target is C$6.88. The highest price target for WEED is C$11.00, while the lowest price target for WEED is C$1.80. The average price target represents a forecasted downside of -32.59% from the current price of C$10.20.

TypeCurrent Forecast
7/23/23 to 7/22/24
1 Month Ago
6/23/23 to 6/22/24
3 Months Ago
4/24/23 to 4/23/24
1 Year Ago
7/23/22 to 7/23/23
Consensus Rating
Reduce
Reduce
Reduce
Reduce
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price TargetC$6.88C$6.88C$3.20C$1.94
Forecasted Upside-32.59% Downside-7.81% Downside12.72% Upside-32.42% Downside
Get Canopy Growth Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter.

WEED Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WEED Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Canopy Growth Stock vs. The Competition

TypeCanopy GrowthMedical Companies
Consensus Rating Score
1.60
2.72
Consensus RatingReduceModerate Buy
News Sentiment RatingNeutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024ATB Capital
4 of 5 stars
 Set TargetSector PerformC$10.00+2.88%
6/11/2024Jefferies Financial Group
2 of 5 stars
 Boost TargetHoldC$4.90 ➝ C$10.63+6.94%
6/4/2024Alliance Global Partners
1 of 5 stars
 Boost TargetC$6.00 ➝ C$11.00+3.38%
5/31/2024CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperformC$4.50 ➝ C$4.00-65.46%
2/14/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$7.00 ➝ C$4.00-15.43%
1/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$1.49 ➝ C$6.70+4.04%
9/15/2023TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$0.70 ➝ C$1.80-1.10%
2/10/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetC$2.00-32.66%
2/10/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$5.00 ➝ C$3.00+1.01%
2/10/2023Eight Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$2.75 ➝ C$1.75-41.08%
2/10/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$2.90 ➝ C$2.40-19.19%
9/30/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual WeightC$2.75-28.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:20 AM ET.

WEED Forecast - Frequently Asked Questions

What is Canopy Growth's forecast for 2024?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Canopy Growth is C$6.88, with a high forecast of C$11.00 and a low forecast of C$1.80.

Should I buy or sell Canopy Growth stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" WEED shares.

Does Canopy Growth's stock price have much downside?

According to analysts, Canopy Growth's stock has a predicted downside of -7.81% based on their 12-month stock forecasts.

What analysts cover Canopy Growth?

Canopy Growth has been rated by research analysts at Alliance Global Partners, ATB Capital, CIBC, and Jefferies Financial Group in the past 90 days.

Do Wall Street analysts like Canopy Growth more than its competitors?

Analysts like Canopy Growth less than other "medical" companies. The consensus rating for Canopy Growth is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how WEED compares to other companies.


This page (TSE:WEED) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners